Abetalipoproteinemia
Jagdish Kathwate
MD Pediatrics. Assistant Professor, Government Medical College, Aurangabad, India.
First Created: 08/01/2015  Last Updated: 08/01/2015

Patient Education

What Is Abetalipoproteinemia?

Abetalipoproteinemia (ABL) is an inherited condition that prevents the body from completely absorbing certain dietary fats. Without treatment, it can cause vitamin deficiencies that may have long term effects on your health. It is caused by a defective gene. Therefore, it runs in families. It is not contagious.

What Causes Abetalipoproteinemia?

ABL is caused by problems with a gene that combine fats with protein to make something called a lipoprotein. ABL is a recessive condition.

What are Symptoms of Abetalipoproteinemia?

  • abnormal growth patterns in infants - developmental delays or “failure to thrive”

  • curving of the spine

  • problems with balance and dexterity

  • problems with coordination

  • muscle weakness

  • protruding abdomen

  • problems with vision

  • speech disorders, slurring of speech

  • fatty, frothy, foul-smelling, or otherwise irregular stools

How to Diagnose Abetalipoproteinemia?

Tests for deficiencies in vitamins A, D, E, and K are common. Doctors may also test your levels of apolipoprotein B. Apolipoprotein B metabolism can be altered in people with ABL and other lipid disorders.

  • Eye exams to diagnose vision problems.

  • Stool samples to see if your stool shows any of the classic signs of the condition.

  • Electromyography to test your muscle activity and see if it has been affected by the condition.

What is Treatment of Abetalipoproteinemia?

ABL is usually treated with high doses of fat-soluble vitamins. You may also receive other supplements, including linoleic acid - an omega-6 fatty acid.

Diet can be an important part of treating ABL. Your doctor may recommend speaking to a nutritionist who can help you lower your fat intake. This might involve changing to skim milk or eating smaller servings of meat and other fatty foods.


1. Newman RP, Schaefer EJ, Thomas CB, Oldfield EH. Abetalipoproteinemia and metastatic spinal cord glioblastoma. Arch Neurol. 1984 May;41(5):554-6. PubMed PMID: 6326713
2. Al-Shali K, Wang J, Rosen F, Hegele RA. Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia. Clin Genet. 2003 Feb;63(2):135-8. PubMed PMID: 12630961.
3. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management Jooho Lee & Robert A. Hegele Inherit Metab Dis (2014) 37:333–339


Abetalipoproteinemia Abetalipoproteinemia 08/01/2015
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0